# Cytoflavin in the Complex Rehabilitation of Stroke Patients

Study · id `cardio:ct-nct05935787` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05935787](<https://clinicaltrials.gov/study/NCT05935787>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05935787

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

## Technical summary

Registry record NCT05935787. Randomized; triple masking; primary purpose treatment. Start 2023-06-30 (actual); primary completion 2024-06-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 240 participants (enrolled count; ClinicalTrials.gov record NCT05935787, source copy `cardio:ctgov-nct05935787-2026-04-14`, retrieved 2026-10-26)
- Started: 2023-06-30 (actual) (ClinicalTrials.gov record NCT05935787, source copy `cardio:ctgov-nct05935787-2026-04-14`, retrieved 2026-10-26)
- Primary completion: 2024-06-26 (actual) (ClinicalTrials.gov record NCT05935787, source copy `cardio:ctgov-nct05935787-2026-04-14`, retrieved 2026-10-26)
- Completion: 2024-12-07 (actual) (ClinicalTrials.gov record NCT05935787, source copy `cardio:ctgov-nct05935787-2026-04-14`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT05935787, source copy `cardio:ctgov-nct05935787-2026-04-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05935787-2026-04-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cytoflavin in the Complex Rehabilitation of Stroke Patients
- Condition: Stroke
- Intervention (Drug): Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
- Intervention (Drug): Placebo
- Lead sponsor: POLYSAN Scientific & Technological Pharmaceutical Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 03d56014263942e2136d626f24572fe388914949a447fdda4d14d475ec2404eb
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
